Although patient-derived GBM samples have been shown to be highly resistant to apoptosis77, our data revealed changes in the expression of various members of Bcl2 family and NF-κB signaling pathway after co-treatment of Bay 11-7082 and TMZ. The gene discussed is BCL2; the disease is glioblastoma.